Coya Therapeutics amends filing to name Mark Pavao to audit committee

Reuters2026/08/07 21:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Coya Therapeutics filed an amended Form 8-K to update board committee assignments disclosed in its March 29, 2026 report.
Mark H. Pavao was appointed to the board’s Audit Committee on Aug. 6, 2026, effective immediately.
The Audit Committee now includes Dov Goldstein as chair, Ann Lee, Dieter Weinand, Mark H. Pavao.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-340449), on August 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Coya Therapeutics amends filing to name Mark Pavao to audit committee

You may also like

Crypto prices